glp 1 agonist and dementia Could diabetes weight loss drugs treat Alzheimer's disease? GLP-1 receptor agonist diabetes medications

These findings emphasize the critical role of the MIA in neurodevelopmental disorders and supports resveratrols protective potential (Zeng et al., 2024)

Urol 1991

GLP-1 promotes the release of insulin to regulate blood sugar (glucose) levels and appetite

Ren W, Xia Y, Chen S, Wu G, Bazer FW, Zhou B, et al

Enhance hydration for skin that looks healthier and more radiant

We abstracted all relevant data reported in the included trials, including treatment discontinuation due to adverse events, all-cause death, cardiovascular disease, non-fatal stroke, kidney failure, severe hypoglycaemia, eye disease requiring intervention, health-related quality of life, serious gastrointestinal events, etc